308 related articles for article (PubMed ID: 3016541)
1. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
Allain JP
N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
[No Abstract] [Full Text] [Related]
2. LAV/HTLV-III seroconversion and disease in hemophiliacs treated in France.
Mathez D; Leibovitch J; Sultan Y; Maisonneuve P
N Engl J Med; 1986 Jan; 314(2):118-9. PubMed ID: 3079879
[No Abstract] [Full Text] [Related]
3. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
[TBL] [Abstract][Full Text] [Related]
4. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
Muncunill J; Forteza A; Forner N; Forteza-Rei J
Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
[No Abstract] [Full Text] [Related]
5. HTLV-III/LAV-seronegative, virus-negative sexual partners and household contacts of hemophiliacs.
McFadden T; Jason JM; Feorino P
JAMA; 1986 Apr; 255(13):1702. PubMed ID: 3005673
[No Abstract] [Full Text] [Related]
6. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies].
Aymard JP; Janot C; Briquel ME; André E; Schooneman F; Vigneron C; Legras B; Alexandre P; Streiff F
Pathol Biol (Paris); 1985 Dec; 33(10):951-6. PubMed ID: 3005949
[TBL] [Abstract][Full Text] [Related]
7. [Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives].
Evensen SA; Frøland SS; Glomstein A
Tidsskr Nor Laegeforen; 1986 Jan; 106(1):19-21. PubMed ID: 3006278
[No Abstract] [Full Text] [Related]
8. [Epidemiology of infection by LAV/HTLV-III virus in hemophiliacs multitransfused in France. Results of a survey conducted by 28 hemophilia centers].
Sultan Y
Nouv Rev Fr Hematol (1978); 1986; 28(5):327-9. PubMed ID: 3643509
[TBL] [Abstract][Full Text] [Related]
9. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS.
Chorba TL; Jason JM; Ramsey RB; Lechner K; Pabinger-Fasching I; Kalyanaraman VS; McDougal JS; Cabradilla CD; Tregillus LC; Lawrence DN
Thromb Haemost; 1985 Apr; 53(2):180-2. PubMed ID: 2992112
[TBL] [Abstract][Full Text] [Related]
10. [Anti-HTLV-III/Lav antibodies, clinical symptoms and immunological determinations in hemophilia patients in Buenos Aires].
Anselmo A; Muchinik G; Pérez Bianco R; de la Barrera S; Riera NE; de Bracco MM; de Tezanos Pinto M
Medicina (B Aires); 1985; 45(3):312-3. PubMed ID: 3870213
[No Abstract] [Full Text] [Related]
11. Lack of correlation between promiscuity and seropositivity to HTLV-III from a low-incidence area for AIDS.
Calabrese LH; Proffitt MR; Rehm S; Lederman M; Carey JT; Houser HB; Edmonds K; Ellner JJ
N Engl J Med; 1985 May; 312(19):1256-7. PubMed ID: 2985988
[No Abstract] [Full Text] [Related]
12. Hemophiliacs and acquired immune deficiency syndrome.
Lin TA; Zhao JQ; Rabin B
Chin Med J (Engl); 1985 Jun; 98(6):444-6. PubMed ID: 2996841
[No Abstract] [Full Text] [Related]
13. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX
Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827
[TBL] [Abstract][Full Text] [Related]
14. [The occurrence of LAV/HTLV III antibodies in patients with hemophilia in the County of Funen].
Larsen FS; Høst A; Munk-Andersen G
Ugeskr Laeger; 1986 Mar; 148(14):865-7. PubMed ID: 3010526
[No Abstract] [Full Text] [Related]
15. [AIDS (acquired immune deficiency syndrome)].
Altay G
Mikrobiyol Bul; 1985 Oct; 19(4):238-51. PubMed ID: 3007947
[No Abstract] [Full Text] [Related]
16. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
[TBL] [Abstract][Full Text] [Related]
17. [LAV/HTLV-III antibodies in blood and blood products].
Gürtler L; Eberle J; Deinhardt F
Dtsch Med Wochenschr; 1985 Oct; 110(43):1639-40. PubMed ID: 2994977
[No Abstract] [Full Text] [Related]
18. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
[No Abstract] [Full Text] [Related]
19. A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses.
Stein SF; Evatt BL; McDougal JS; Lawrence DN; Holman RC; Ramsey RB; Spira TJ
Blood; 1985 Oct; 66(4):973-9. PubMed ID: 2994784
[TBL] [Abstract][Full Text] [Related]
20. Acquired immune deficiency syndrome (AIDS) HTLV III/LAV; the causal agent and modes of transmission.
Smithies A
Health Bull (Edinb); 1986 Jul; 44(4):234-8. PubMed ID: 3017891
[No Abstract] [Full Text] [Related]
[Next] [New Search]
